|Mr. Robert S. Weiss||Chief Exec. Officer, Pres and Non-Independent Director||2.04M||13.1M||70|
|Mr. Albert G. White III||Chief Financial Officer, Chief Strategic Officer and Exec. VP||938.05k||3.45M||47|
|Mr. Daniel G. McBride Esq.||Chief Operating Officer, Exec. VP and Pres of CooperVision Inc||957.69k||1.22M||53|
|Ms. Carol R. Kaufmann||Chief Admin. Officer, Chief Governance Officer, Exec. VP and Sec.||844.81k||6.45M||68|
|Mr. Kim Duncan||VP of Investor Relations||N/A||N/A||N/A|
The Cooper Companies, Inc. operates as a medical device company worldwide. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides medical devices, surgical instruments, accessories, and diagnostic products and services for health care professionals and institutions focusing on womens health, fertility, and genetic testing in hospitals, clinicians offices, and fertility clinics. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
The Cooper Companies, Inc.’s ISS Governance QualityScore as of September 1, 2017 is 6. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 7; Compensation: 3.